Myfortic 180 mg/1

Myfortic 180 mg is a delayed-release tablet containing mycophenolic acid, used to prevent organ rejection post-transplant. It is commonly prescribed for kidney transplant patients.

Myfortic 180 mg is primarily used to prevent rejection of transplanted organs, particularly kidneys. It works by suppressing the immune system to help the body accept the new organ. This medication is often prescribed in combination with other immunosuppressants. Patients may wonder, 'What is Myfortic used for?' It is specifically designed to aid in the acceptance of transplanted organs.

Common effects of Myfortic 180 mg may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue or an increased risk of infections due to its immune-suppressing properties. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Myfortic 180 mg should be handled with care, as it can increase the risk of infections and other complications. It is essential to follow the prescribed dosage and administration instructions closely. Patients should avoid activities that may increase the risk of injury or infection while taking this medication. Regular blood tests may be required to monitor the body's response to the drug.

Myfortic 180 mg may interact with other medications, including antacids containing magnesium or aluminum, which can reduce its effectiveness. It is also important to avoid taking it with cholesterol-lowering drugs like cholestyramine. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.